Sub Banner Image

Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA Alerts

Market Impact

Vandana Singh

·

April 15, 2025

·

Benzinga

FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown contents and unverified sterility.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.